I B Kerr

1.8k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

I B Kerr is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, I B Kerr has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in I B Kerr's work include Genetic factors in colorectal cancer (5 papers), RNA modifications and cancer (2 papers) and Peptidase Inhibition and Analysis (2 papers). I B Kerr is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), RNA modifications and cancer (2 papers) and Peptidase Inhibition and Analysis (2 papers). I B Kerr collaborates with scholars based in United Kingdom, Switzerland and India. I B Kerr's co-authors include David P. Lane, Andrew Rowan, Julian Gannon, Nanda R. Rodrigues, Walter F. Bodmer, Mark E. Smith, Demetrios�� Spandidos, Newell W. Johnson, Dhananjaya Saranath and Rekha G. Panchal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gut and British Journal of Cancer.

In The Last Decade

I B Kerr

14 papers receiving 1.5k citations

Hit Papers

p53 mutations in colorectal cancer. 1990 2026 2002 2014 1990 250 500 750

Peers

I B Kerr
Gauri C. Bedi United States
CS Potten United Kingdom
Peter van der Riet United States
Ning T. Yeh United States
Quintin Pan United States
Ajay Matta Canada
Siegina G. Evers Netherlands
Gauri C. Bedi United States
I B Kerr
Citations per year, relative to I B Kerr I B Kerr (= 1×) peers Gauri C. Bedi

Countries citing papers authored by I B Kerr

Since Specialization
Citations

This map shows the geographic impact of I B Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I B Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I B Kerr more than expected).

Fields of papers citing papers by I B Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I B Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I B Kerr. The network helps show where I B Kerr may publish in the future.

Co-authorship network of co-authors of I B Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of I B Kerr. A scholar is included among the top collaborators of I B Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I B Kerr. I B Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Heinrich, Peter C., Fabiana Horn, Lutz Graeve, et al.. (1998). Interleukin-6 and related cytokines: effect on the acute phase reaction.. PubMed. 37 Suppl 1. 43–9. 44 indexed citations
2.
Saranath, Dhananjaya, et al.. (1991). High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. British Journal of Cancer. 63(4). 573–578. 203 indexed citations
3.
Scholefield, J H, et al.. (1991). Human papillomavirus type 16 DNA in anal cancers from six different countries.. Gut. 32(6). 674–676. 20 indexed citations
4.
Skillings, Jamey, MN Levine, E. Eisenhauer, et al.. (1991). Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.. PubMed. 144(3). 297–301. 8 indexed citations
5.
Rodrigues, Nanda R., Andrew Rowan, Mark E. Smith, et al.. (1990). p53 mutations in colorectal cancer.. Proceedings of the National Academy of Sciences. 87(19). 7555–7559. 895 indexed citations breakdown →
6.
Kerr, I B. (1989). Molecular genetics of colorectal carcinoma.. BMJ. 299(6700). 637–638. 9 indexed citations
7.
8.
Kerr, I B, et al.. (1986). Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.. PubMed. 70(7). 881–3. 10 indexed citations
9.
Kerr, I B, et al.. (1986). The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma. British Journal of Cancer. 53(2). 231–235. 29 indexed citations
10.
Jack, Andrew, et al.. (1986). The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry. British Journal of Cancer. 53(6). 713–719. 28 indexed citations
11.
Kerr, I B, et al.. (1986). Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease. The Journal of Pathology. 150(3). 163–167. 22 indexed citations
12.
13.
Spandidos, Demetrios�� & I B Kerr. (1984). Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum. British Journal of Cancer. 49(6). 681–688. 153 indexed citations
14.
Teixeira, Geoffrey, et al.. (1969). [Experimental South American blastomycosis in the rat. Development of the experimental disease in animals infected with Yoshida sarcoma].. PubMed. 75(2). 505–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026